Price chart (1D to 10Y)
Licensed market data — shown to members, not published to the open web.
Portfolio · 30 Jun 2026
From the fund’s own N-PORT filingThe fund’s disclosed portfolio, not an index membership list. Showing the largest 25 positions. The ten largest identified positions carry 70.2% of the portfolio.
| # | Holding | Sector | Country | Weight | Filed value |
|---|---|---|---|---|---|
| 1 | Amgen Inc AMGN | Healthcare | United States | 15.24% | $60.31M |
| 2 | Gilead Sciences Inc GILD | Healthcare | United States | 12.78% | $50.57M |
| 3 | Vertex Pharmaceuticals Inc VRTX | Healthcare | United States | 9.10% | $36.00M |
| 4 | Regeneron Pharmaceuticals Inc REGN | Healthcare | United States | 6.20% | $24.55M |
| 5 | Revolution Medicines Inc RVMD | Healthcare | United States | 5.27% | $20.85M |
| 6 | Argenx SE ARGX | Healthcare | Netherlands | 4.97% | $19.66M |
Source: SEC filings. Information and analytics, not investment advice.